Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol sedation after endovascular treatment for acute stroke
ChiCTR2100045420Phase 4Recruiting
- Sponsor
- Xiangtan Central Hospital
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in ischemic stroke comparing Experimental - remimazolam with Control - propofol (2 arms). Primary endpoints: Incidence of sedative hypotension requiring treatment and Incidence of respiratory depression during sedation. Started Apr 2021; status: recruiting.
02
Drugs
remimazolampropofol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2100045420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045420.